10 -"The-Netherlands-Cancer-Institute-(NKI)" "The Netherlands Cancer Institute" positions
Sort by
Refine Your Search
-
Category
-
Field
-
, and biobanks with patient materials. The project is a close collaboration with researchers and clinicians from The Netherlands Cancer Institute and Katholieke Universiteit Leuven. As a team, we
-
The research group of Reuven Agami at the division of Oncogenomics at the Netherlands Cancer Institute in Amsterdam has recently uncovered a novel phenomenon in cancer termed “Sloppiness
-
27 Apr 2024 Job Information Organisation/Company The Netherlands Cancer Institute Research Field Medical sciences Physics Researcher Profile Recognised Researcher (R2) First Stage Researcher (R1
-
13 Apr 2024 Job Information Organisation/Company The Netherlands Cancer Institute Research Field Cultural studies Other Economics Medical sciences Researcher Profile Recognised Researcher (R2) First
-
4 Apr 2024 Job Information Organisation/Company The Netherlands Cancer Institute Research Field Physics Other Medical sciences Researcher Profile Recognised Researcher (R2) First Stage Researcher
-
of Amsterdam UMC Cancer Center Amsterdam and Netherlands Cancer Institute, VU and UvA (OOA) dedicated to the training of more than 1000 PhD students working in the field of Oncology. Finally, you will
-
department at the Amsterdam University Medical Centers (Amsterdam UMCs) as well as close collaborations with parties as the Netherlands Cancer Institute. In qurAI we focus on the development and clinical
-
) of the University of Amsterdam, with strong ties with clinical department at the Amsterdam University Medical Centers (Amsterdam UMCs) as well as close collaborations with parties as the Netherlands Cancer Institute
-
department at the Amsterdam University Medical Centers (Amsterdam UMCs) as well as close collaborations with parties as the Netherlands Cancer Institute. In qurAI we focus on the development and clinical
-
the university medical centers of Utrecht and Groningen, the Netherlands Cancer Institute, and Oncode Institute have joined forces with (inter)national pharmaceutical and biotech companies to form a